Tokyo - Delayed Quote JPY

Sundrug Co.,Ltd. (9989.T)

4,514.00
+15.00
+(0.33%)
At close: 3:30:00 PM GMT+9
Loading Chart for 9989.T
  • Previous Close 4,499.00
  • Open 4,515.00
  • Bid 4,502.00 x --
  • Ask 4,515.00 x --
  • Day's Range 4,483.00 - 4,526.00
  • 52 Week Range 3,439.00 - 4,883.00
  • Volume 389,100
  • Avg. Volume 439,378
  • Market Cap (intraday) 527.989B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 17.51
  • EPS (TTM) 257.79
  • Earnings Date Aug 12, 2025 - Aug 18, 2025
  • Forward Dividend & Yield 132.00 (2.93%)
  • Ex-Dividend Date Sep 29, 2025
  • 1y Target Est 5,105.00

Sundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan. The company operates through Drug Store Business and Discount Store Business segments. The Drug Store Business segment primarily sells pharmaceutical products, cosmetics, and daily necessities. The Discount Store Business segment offers food and household products. The company was founded in 1957 and is headquartered in Fuchu, Japan.

www.sundrug.co.jp

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: 9989.T

View More

Performance Overview: 9989.T

Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

9989.T
13.90%
Nikkei 225 (^N225)
6.51%

1-Year Return

9989.T
14.64%
Nikkei 225 (^N225)
4.23%

3-Year Return

9989.T
80.10%
Nikkei 225 (^N225)
39.49%

5-Year Return

9989.T
49.63%
Nikkei 225 (^N225)
81.48%

Compare To: 9989.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 9989.T

View More

Valuation Measures

Annual
As of 5/20/2025
  • Market Cap

    526.24B

  • Enterprise Value

    499.65B

  • Trailing P/E

    17.44

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.67

  • Price/Book (mrq)

    2.00

  • Enterprise Value/Revenue

    0.63

  • Enterprise Value/EBITDA

    11.88

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.84%

  • Return on Assets (ttm)

    6.44%

  • Return on Equity (ttm)

    11.76%

  • Revenue (ttm)

    801.81B

  • Net Income Avi to Common (ttm)

    30.75B

  • Diluted EPS (ttm)

    257.79

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    64.96B

  • Total Debt/Equity (mrq)

    14.34%

  • Levered Free Cash Flow (ttm)

    689.12M

Research Analysis: 9989.T

View More

Company Insights: 9989.T

Research Reports: 9989.T

View More

People Also Watch